Silverarc Capital Management’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.88M Buy
286,807
+167,311
+140% +$2.26M 0.72% 29
2025
Q1
$897K Buy
+119,496
New +$897K 0.18% 62